David Moreno-Ramirez
Overview
Explore the profile of David Moreno-Ramirez including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
71
Citations
974
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Saiag P, Lebbe C, Brochez L, Emile J, Forsea A, Harwood C, et al.
Eur J Cancer
. 2025 Feb;
218:115265.
PMID: 39904126
Dermatofibrosarcoma protuberans (DFSP) is a cutaneous fibroblastic tumour that is locally aggressive, with a tendency for local recurrence, but rarely metastasizes. A collaboration of multi-disciplinary experts from the European Association...
2.
Garbe C, Amaral T, Peris K, Hauschild A, Arenberger P, Basset-Seguin N, et al.
Eur J Cancer
. 2024 Dec;
215:115153.
PMID: 39709737
A unique collaboration of multi-disciplinary experts from the European Association of Dermato-Oncology (EADO), the European Dermatology Forum (EDF), and the European Organization of Research and Treatment of Cancer (EORTC) was...
3.
European consensus-based interdisciplinary guideline for melanoma. Part 1: Diagnostics - Update 2024
Garbe C, Amaral T, Peris K, Hauschild A, Arenberger P, Basset-Seguin N, et al.
Eur J Cancer
. 2024 Dec;
215:115152.
PMID: 39700658
This guideline was developed in close collaboration with multidisciplinary experts from the European Association of Dermato-Oncology (EADO), the European Dermatology Forum (EDF) and the European Organization for Research and Treatment...
4.
Coto-Segura P, Segu-Verges C, Martorell A, Moreno-Ramirez D, Jorba G, Junet V, et al.
Front Immunol
. 2023 Oct;
14:1212981.
PMID: 37809085
Background: Psoriasis is a chronic immune-mediated inflammatory systemic disease with skin manifestations characterized by erythematous, scaly, itchy and/or painful plaques resulting from hyperproliferation of keratinocytes. Certolizumab pegol [CZP], a PEGylated...
5.
Stratigos A, Garbe C, Dessinioti C, Lebbe C, van Akkooi A, Bataille V, et al.
Eur J Cancer
. 2023 Sep;
193:113251.
PMID: 37717283
Invasive cutaneous squamous cell carcinoma (cSCC) is one of the most common cancers in white populations, accounting for 20% of all cutaneous malignancies. Overall, cSCC mostly has very good prognosis...
6.
Stratigos A, Garbe C, Dessinioti C, Lebbe C, van Akkooi A, Bataille V, et al.
Eur J Cancer
. 2023 Sep;
193:113252.
PMID: 37708630
In order to update recommendations on treatment, supportive care, education, and follow-up of patients with invasive cutaneous squamous cell carcinoma (cSCC), a multidisciplinary panel of experts from the European Association...
7.
Peris K, Fargnoli M, Kaufmann R, Arenberger P, Bastholt L, Basset Seguin N, et al.
Eur J Cancer
. 2023 Aug;
192:113254.
PMID: 37604067
Basal cell carcinoma (BCC) is the most common malignant tumour in white populations. Multidisciplinary experts from European Association of Dermato-Oncology (EADO), European Dermatology Forum, European Society for Radiotherapy and Oncology...
8.
Bossi P, Ascierto P, Basset-Seguin N, Dreno B, Dummer R, Hauschild A, et al.
Crit Rev Oncol Hematol
. 2023 Jul;
189:104066.
PMID: 37442495
Basal cell carcinoma (BCC), the most common type of skin cancer, is characterized by aberrant activation of the hedgehog molecular pathway. Systemic therapy is indicated when local approaches, such as...
9.
Campana L, Farronato S, Hodgetts J, Odili J, Vecchiato A, Bracken A, et al.
Br J Surg
. 2023 May;
110(7):818-830.
PMID: 37131298
Background: Skin metastases are an important co-morbidity in melanoma. Despite broad adoption, electrochemotherapy implementation is hindered by a lack of treatment indications, uncertainty regarding procedural aspects, and the absence of...
10.
Silva-Claveria F, Alvarez-Munoz A, Ferrandiz L, Fernandez-Orland A, Conde-Martin A, Moreno-Ramirez D, et al.
Int J Surg Pathol
. 2023 Feb;
31(7):1398-1402.
PMID: 36803128
BRCA1-associated protein 1 (BAP1)-inactivated melanomas can occur sporadically or in germline contexts, particularly in recently recognized BAP1-tumor predisposition syndrome. Diagnosis represents a clinical and histopathological challenge, requiring comprehensive analysis of...